Trace elements have beneficial, as well as detrimental effects on bone homeostasis

Physiological Research

Volumn 66, Issue 3, 2017, Pages 391-402

  Zofkova, I ^a   Davis, M ^b   Blahos, J ^c  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b Ecologia Environment   (Australia)

^c CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Bone mineral density; Bone quality; Boron; Cadmium; Copper; Fluoride; Iron; Lead; Magnesium; Manganese; Selenium; Zinc

Indexed keywords

CADMIUM; IRON; LEAD; MAGNESIUM; TRACE ELEMENT;

ANIMAL; BONE DENSITY; DRUG EFFECTS; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE DENSITY; CADMIUM; HOMEOSTASIS; HUMANS; IRON; LEAD; MAGNESIUM; TRACE ELEMENTS;

EID: 85019483629     PISSN: 08628408     EISSN: 18029973     Source Type: Journal    
DOI: 10.33549/physiolres.933454     Document Type: Review

References (93)

1. AINA V, LUSVARDI G, ANNAZ B, GIBBON IR, IMRIE FE, MALAVASI G, MENABUE L, CARRATO G, MARTRA G: Magnesium-and stroncium-co-substituted hydroxyapatite: the effects of doped-ions on the structure and chemico-physical properties. J Mater Sci Mater Med 23: 2867-2979, 2012.
2. AKESSON A, BJELLERUP P, LUNDH T, LIDFELDT J, NERBRAND C, SAMSIOE G, SAMSIOE G, SKERFVING S, VAHTER M: Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 114: 830-834, 2006.
3. ANDREWS RE, SHAH KM, WILKINSON JM, GARTLAND A: Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health. Bone 49: 717-723, 2011.
4. ARIKAN DC, COSKUN A, OZER A, KILINC M, ATALAY F, ARIKAN T: Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res 144: 407-417, 2011.
5. ATIK OS, USLU MM, EKSIOGLU F, SATANA T: Etiology of senile osteoporosis. a hypothesis. Clin Orthopaed Related Res 443: 25-27, 2006.
6. BERGER PK, POLLOCK NK, LAING EM, CHERTIN V, BERNARD PJ, GRIDER A, SHAPSES SA, DING KH, ISALES CM, LEWIS RD: Zinc supplementation increases procollagen type 1 amino-terminal propeptide in premenarcheal girls: a randomized controlled trial. J Nutr 145: 2699-2704, 2015.
7. BIER EE, INZANA JA, SUDU TJ, SHU L, PUZAS JE, MONEY RA: Effects of combined exposition to lead and highfat diet on bone quality in juvenile mice. Environ Health Perspect 123: 935-943, 2015.
8. BISHAK YK, PAYAHOO L, OSATDRAHIMI A, NOURAZARIAN A: Mechanisms of cadmium carcinogenicity in the gastrointestinal act. Asian Pac J Cancer Prev 16: 9-21, 2015.
9. BORTOLIN RH, DA GRACA AVEZEDO AREU BJ, ABBOLTT CALVAO URURAHY M, COSTA DE SOUZA KS, BEZERRA JF, LOUREIRO MB, DA SILVA FS, MARQUES DE, BATISTA AA, OLIVEIRA G, ET AL.: Protection against T1DM-induced bone loss by zinc supplementation: biomechanical, histomorphometric, and molecular analyses in STZ-induced diabetic rats. PLoS One 10: e0125349, 2015.
10. BREWER GJ: Copper in medicine. Curr Opin Chem Biol 7: 207-212, 2003.
11. BRZóSKA MM, ROGALSKA J, GALAZYN-SIDORCZUK M, JURCZUK M, ROSZCZENKO A, KULIKOWSKA-KARPINSKA E, MONIOSZKO-JAKONIUK J: Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium. Toxicology 237: 89-103, 2007.
12. CAO JJ, GREGOIRE BR, ZENG H: Selenium deficiency decreases antioxidative capacity and is detrimental to bone microarchitecture in mice. J Nutr 142: 1526-1531, 2012.
13. CASTIGLIONI S, CAZZANIGA A, ALBISETTI W, MAIER JA: Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients 5: 3022-3033, 2013.
14. CHACHRA D, LIMEBACK H, WILLETT TL, GRYNPAS MD: The long-term effects of water fluoridation on the human skeleton. J Dent Res 89: 1219-1223, 2010.
15. CHAYA A, YOSHIZAWA S, VERDELIS K, MYERS N, COSTELLO BJ, CHOU DT, PAL S, MAITI S, KUMTA PN, SFEIR C: In vivo study of magnesium plate and screw degeneration and bone fracture healing. Acta Biomater 18: 262-269, 2015.
16. COYLE L, ENTEZARALMAHDI M, ADEOLA M, DE HOYOS P, MEHED A, VARON J: The perfect storm: copper deficiency presenting as progressive peripheral neuropathy. Am J Emerg Med. 34: 340.e5-340.e6, 2016.
17. DEVIRIAN TA, VOLPE SL: The physiological effects of dietary boron. Crit Rev Food Sci Nutr 43: 219-231, 2003.
18. DIAZ-CASTRO J, LóPEZ-FRIAS MR, CAMPOS MS, LóPEZ-FRIAS M, ALFéREZ MJ, NESTARES T, OJEDA ML, LóPEZ-ALIAGA I: Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats. Eur J Nutr 51: 241-247, 2012.
19. DIAZ-CASTRO J, RAMíREZ LóPEZ-FRIAS M, CAMPOS MS, LóPEZ-FRIAS M, ALFéREZ MJ, NESTARES T, ORTEGA E, LóPEZ-ALIAGA I: Goat milk during iron repletion improves bone turnover impaired by severe iron deficiency. J Diary Sci 94: 2752-2761, 2011.
20. ENGSTRöM A, MICHAELSSON K, VATER M, JULIN B, WOLK A, äKESSON A: Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone 50: 1372-1378, 2012.
21. FAYHOE RP, LENTJES MA, LUBEN RN, KHAW KT, WELCH A: Dietary magnesium and potassium intakes and circulating magnesium are associated with heel bone ultrasound attenuation and osteoporotic fracture risk in the EPIC-Norfolk cohort study. Am J Clin Nutr 102: 376-384, 2015.
22. GONZALEZ-REIMERS E, DURAN-CASTELLON M, MARTIN-OLIVERA R, POLEZ-RAMíREZ A, GARCIAVALDECASAS COPMPELO E: Effects of zinc supplementation on ethanol-mediated bone alterations. Food Chem Toxicol 43: 1497-1505, 2005.
23. GREY A, GARG S, DRAY M, PURVIS L, HORNE A, CALLON K, GAMBLE G, BOLLAND M, REID IR, CUNDY T: Low-dose fluoride in postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 98: 2301-2307, 2013.
24. GUGGENBUHL P, DEUGNIER Y, BOISDET JF, ROLLAND Y, PERDRIGER A, PAWLOTSKY Y, CHALES G: Bone mineral density in men with genetic hemochromatosis and HFGE gene mutation. Osteoporosis Int 16: 1809-1814, 2005.
25. HAKKI SS, DUNDAR N, KAYIS SA, HAKKI EE, HAMURCU, KERIMOGLU U, BASPINAR N, BASOVOU A, NIELSEN FH: Boron enhances strength and alters mineral composition of bone in rabbits fed a high energy diet. J Trace Elem Med Biol 27: 148-153, 2013.
26. HEADLEY KB, NEWMAN SM, HUNT JR: Dietary zinc reduces osteoclast resorption activities and increases markers of osteoblast differentiation, matrix maturation, and mineralization in the long bones of growing rats. J Nutr Biochem 21: 297-303, 2010.
27. HILL T, MEUNIER N, ANDRIOLLO-SANCHEZ M, CIARAPICA D, HININGER-FAVIER I, POLITO A, O'CONNOR JM, COUDRAY C, CASHMAN KF: The relationship between the zinc nutritive status and biochemical markers of bone turnover in older European adults: the ZENITH study. Eur J Clin Nutr 59 (Suppl 2): S73-S78, 2005.
28. HOEG A, GOGAKOS A, MURENY E, MUELLER S, KöHRLE J, REID DM, GLüER CC, FELSENBERG D, ROUX C, EASTELL R, SCHONBURG L, WILLIAMS GR: Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. Clin Endocrinol Metab 97: 4061-4070, 2012.
29. HORDYJEWSKA A, POPIOLEK L, KOCOT J: The many faces" of copper in medicine and treatment. Biometals 27: 611-621, 2014.
30. HOSEA HJ, TAYLOR CG, WOOD T, MOLLARD R, WEILER HA: Zinc-deficient rats have more limited bone recovery during repletion than diet-restricted rats. Exp Biol Med (Maywood) 229: 303-311, 2004.
31. HREHA J, WEY A, CUNNINGHAM C, KRELL ES, BRIETBART EA, PAGLIA DN, MONTEMURRO NJ, NGUYEN DA, LEE YJ, KOMLOS D, ET AL.: Local manganese chloride treatment accelerates fracture healing in a rat model. J Orthop Res 33: 122-130, 2015.
32. HUNT CD: Dietary boron: progress in establishing essentials roles in human physiology. J Trace Elem Med Biol 26: 2-3, 2012.
33. JAMIESON JA, TAILOR CG, WEILER HA: Marginal zinc deficiency exacerbates bone lead accumulation and high dietary zinc attenuates lead accumulation at the expense of bone density in growing rats. Toxicol Sci 2006: 286-249, 2006.
34. JHA SK, MISHRA VK, SHARMA DK, DAMODARAN T: Fluoride in the environment and its humans. Rev Environ Contam Toxicol 211: 121-142, 2011.
35. KHANDARE AL, SURESH P, KUMAR PU, LAKSMAIAH N, MANULA N, RAO G: Beneficial effect of copper supplementation on deposition of fluoride in bone in fluoride-and molybdenum-fed rabbits. Calcif Tissue Int 77: 233-238, 2005.
36. KIDO S, FUJIHARA M, NOMUR K, SASAKI S, MUKAI R, OHNISHI R, KANEKO I, SEGAWA H, TATSUMI S, IZUMI H, KOHNO K, MIYAMOTO K: Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells. Toxicol Sci 139: 301-316, 2014.
37. KIM YD, YIM DH, EOM SY, MOON SI, PARK CH, KIM GB, YU SD, CHOI BS, PARK JD, KIM H: Differences in the susceptibility to cadmium-induced renal tubular damage and osteoporosis according to sex. Environ Toxicol Pharmacol 38: 272-278, 2014.
38. KIPPLER M, TOFAIL F, GARDNER R, RAHMAN A, HAMADANI JD, BOTTAI M, VAHTER M: Maternal cadmium exposure during pregnancy and size at birth: a prospective cohort study. Environ Health Perspect 120: 284-289, 2012.
39. KOROGLU BK, ERSOY IH, KOROGLU M, BAKALI A, ERSOY S, VAROL S, TAMER MN: Serum parathyroid hormone levels in chronic endemic fluorosis. Biol Trace Elem Res 143: 79-86, 2011.
40. KUBIAK K, KLIMCZAK A, DZIKI L, MODRANKA R, MALINOWSKA K: Influence of copper (II) complex on the activity of selected oxidative enzymes. (In Polish) Pol Merkur Lekarski 28: 22-25, 2010.
41. KUMAR N, GROSS JB JR, AHLSKOG JE: Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 63: 33-39, 2004.
42. LI BB, YU SF: In vitro study of the effects of copper ion on osteoclastic resorption in various dental mineralized tissues. Zhoghua Kou Qiang Yi Xue Za Zhi 42: 110-113, 2007.
43. LEIDI M, DELLERA F, MARIOTTI M, MAIER JA: High magnesium inhibits human osteoblast differentiation in vitro. Magnes Res 24: 1-6, 2011.
44. LEVY SM, WARREN JJ, PHIPPS K, LETUCHY E, BROFFITT B, EICHENBERGER-GILMORE J, BURNS TL, KAVAND G, JANZ KF, TORNER JC, PAULEY CA: Effects of life-long fluoride intake on bone measures of adolescents: a prospective cohort study. J Dent Res 93: 353-359, 2014.
45. LIANG Y, LEI L, NILSSON J, LI H, NORDBERG M, BERNARD A, NORDBERG GF, BERGDAHL IA, JIN T: Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect 120: 223-228, 2015.
46. LIU R, JIN C, WANG Z, WANG Z, WANG J, WANG L: Effects of manganese deficiency on the microstructure of proximal tiba and OPG/RANKL gene expression in chicks. Vet Res Commun 39: 31-37, 2015.
47. LOWE NM, FRASER WD, JACKSON MJ: Micronutrient group symposium on micronutrient supplementation: is there a case? Is there a potential therapeutic value of copper and zinc for osteoporosis? Proc Nutr Soc 61: 181-185, 2005.
48. MADEIROS DM, STOECKER B, PLATTNER A, JENNINGS D, HAUB M: Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight. J Nutr 34: 3061-3067, 2004.
49. MARET W, SANDSTEAD HH: Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20: 3-18, 2006.
50. MARQUARDT ML, DONE SL, SANDROCK M, BERDON WE, FELDMAN KW: Copper deficiency presenting as metabolic bone disease in extremely low birth weight, short-gut infants. Pediatrics 130: e695-e698, 2012.
51. MEUNIER N, O'CONNOR JM, MAIANI G, CASHMAN KD, SECKER DL, FERRY M, ROUSSEL AM, COUDRAY C: Importance of zinc in the elderly: the ZENITH study. Eur J Clin Nutr 59 (Suppl 2): S1-S4, 2005.
52. MEYER TE, VERWOERT GC, HWANG SJ, GLAZER NL, SMITH AV, VAN ROOIJ FJ, EHRET GB, BOERWINKLE E, FELIX JF, LEAK TS, ET AL.: Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet 6: e1001045, 2010.
53. MIDHAVI-ROSHAN M, EBRAHIMI M, EBRAHIMI A: Cooper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women. Clin Cases Miner Bone Metab 12: 18-21, 2015.
54. MORENO-REYES R, EGRISE D, NÉVE J, PASTEELS JL, SCHOUTENS A: Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 16: 1556-1563, 2001.
55. NAWROT T, GEUSENS P, NULENS TS, NEMERY B: Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res 25: 1441-1445, 2010.
56. NEMCIKOVA P, SPEVACKOVA V, CEJCHANOVA M, HILL M, ZOFKOVA I: Relationship of serum manganese and copper levels to bone density and quality in postmenopausal women. A pilot study. Osteol Bull 14: 97-100, 2009.
57. NIELSEN FH, STOECKER B: Boron and fish oil have different beneficial effects on strength and trabecular microarchitecture of bone. J Trace Elem Med Biol 23: 195-203, 2009.
58. NIEVES JW: Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int 24: 771-786, 2009.
59. OHNO M, KIMOTO K, TOYODA T, KAWATA K, ARAKAWA H: Fluoride-treated bio-resorbable synthetic nonceramic (corrected) hydroxyapatite promotes proliferation and differentiation of human osteoblastic MG-63 cells. J Oral Implantol 39: 154-160, 2013.
60. O'NEAL SL, ZHENG W: Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep 2: 315-328, 2015.
61. PAGE PS, NAZAR RG, PARK MC, JAMES RF: Copper deficiency myelopathy in the setting of advanced degenerative cervical spondylosis. Br J Neurosurg. 30: 453-455, 2016.
62. PALACIOS C: The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr 46: 621-628, 2006.
63. PAN L, SHI X, LIU S, GUO X, ZHAO M, CAI R, SUN G: Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway. Toxicol Lett 225: 34-42, 2014.
64. PAPA V, BIMONTE VM, WANNENES F, D'ABUSCO AS, FITTIPALDI S, SCANDURRA R, POLITI L, CRESCIOLI C, LENZI A, DI LUIGI L, MIGLIACCIO S: The endocrine disruptor cadmium alter human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases. J Endocrinol Invest 38: 1345-1356. 2015.
65. PARELMAN M, STOECKER B, BAKER A, MEDEIROS D: Iron restriction negatively affects bone in female rats and mineralization of hFOB osteoblast cells. Exp Biol Med (Maywood) 231: 378-386, 2006.
66. PLUM LM, RINK L, HAASE H: The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 7: 1342-1365, 2010.
67. PRICE CT, LANGFORDT JR, LIPORACE FA: Essential nutrients for bone health and a review of their availability in the average north american diet. Open Orthop J 6: 143-149, 2012.
68. PURANIK CP, RYAN KA, YIN Z, MARTINEZ-MIER EA, PREISSER JS, EVERETT ET: Fluoride modulates parathyroid hormone secretion in vivo and in vitro. Cells Tissues Organs 200: 413-423, 2015.
69. RAHNAMA M, BLONIARZ J, ZAREBA S, SWIATKOWSKI W: Study of estrogen deficiency impact on manganese levels in teeth and mandible of rats after ovariectomy. Rocz Panstw Zakl Hig 54: 33-38, 2003.
70. RICO H, GóMEZ-RASO N, SEVILLA M, HERNáNDFEZ ER, SECO C, PáEZ E, CRESPO E: Effects on bone loss of manganese alone or with copper supplement in ovariectomized rats. a morphometric and densitometric study. Eur J Obstet Gynecol Reprod Biol 90: 97-101, 2000.
71. RUDE RK, SINGER FR, GRUBER HE: Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 28: 131-141, 2009.
72. RUNNELS LW: TRPM6 and TRPM7: a Mul-TRP-PLIK-cation of channel functions. Curr Pharm Biotechnol 12: 42-53, 2011.
73. RYZ NR, WEILER HA, TAILOR CG: Zinc deficiency reduces bone mineral density in the spine of young adult rats: a pilot study. Ann Nutr Metab 54: 218-26, 2009.
74. SADEGHI N, OVEISI MR, NAHNAT B, HAJIMAHMOODI M, BEHZAD M, BEHFAR A, SADEGHI F, SAADATMAND S: The relationship between bone health and plasma zinc, copper, lead and cadmium concentration in osteoporotic women. J Environ Health Sci Eng 12: 125, 2014.
75. SAKAI T, WARIISHI M, NISHIYAMA K: Changes in trace element concentrations in hair of growing children. Biol Trace Elem Res 77: 43-51, 2000.
76. SáNCHEZ-GONZáLEZ C, LóPEZ-CHAVES C, GóMEZ-ARACENA J, GALINDO P, ARANDA P, LLOPIS J: Association of plasma manganese levels with chronic renal failure. J Trace Elem Med Biol 31: 78-84, 2015.
77. SIERPINSKA T, KONSTANTYNOWICZ J, ORYWAL K, GOLEBIEWSKA M, SZMITKOWSKI M: Copper deficit as a potential pathogenic factor of reduced bone mineral density and severe tooth wear. Osteoporos Int 25: 447-454, 2014.
78. SONG YE, TAN H, LIU KJ, ZHANG YZ, LIU Y, LU DL, TU J, CUI CY: Effect of fluoride exposure on bone metabolism indicators ALP, BALP, and BGP. Environ Health Prev Med 16: 158-163, 2011.
79. SUZUKI T, KAJITA Y, KATSUMATA S, MATSUZAKI H, SUZUKI K: Zinc deficiency increases serum concentration of parathyroid hormone through a decrease in serum calcium and induces bone fragility in rats. J Nutr Sci Vitaminol (Tokyo) 5: 382-390, 2015.
80. TSAI TL, PAN WH, CHUNG YT, WU TN, TSENG YC, LIOU SH, WANG SL: Association between urinary lead and bone health in a general population from Taiwan. J Expo Sci Environ Epidemiol 26: 481-487, 2016.
81. TURNER CH, GARETTO LP, DUNIPACE AJ, ZHANG W, WILSON ME, GRYNPAS MD, CHACHRA D, MCCLINTOCK R, PEACOCK M, STOOKEY GK: Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength, in rabbits. Calcif Tissue Int 61: 77-83, 1997.
82. VAN LAECKE S, VAN BIESEN W: Hypomagnesaemia in kidney transplantation. Transplant Rev (Orlando) 29: 154-160, 2015.
83. VOLPE SL: Magnesium in disease prevention and overall health. Adv Nutr 4: 378S-383S, 2013.
84. WALLIN M, SALLSTEN G, FABRICIUS-LAGGING, E, OHRN C, LUNDH T, BARREGARD L: Kidney cadmium levels and association with urinary and bone mineral density: a cross-sectional study in Sweden. Environ Health 12: 22, 2013.
85. WONG AK, BEATTIE KA, BHARGAVA A, CHEUNG M, WEBBER CE, CHETTLE DR, PAPAIOANNOU A, ADACHI JD, CANADIAN MULTICENTRE OSTEOPOROSIS STUDY (CaMOS) RESEARCH GROUP: Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women. Bone 79: 58-64, 2015.
86. WRIGHT I, BLANCO-ROJO R, FERNáNDEZ MC, TOXQUI L, MORENO G, PéREZ-GRANADOS AM, DE LA PIEDRA C, REMACHA áF, VAQUERO MP: Bone remodelling is reduced by recovery from iron deficiency anaemia in premenopausal women. J Physiol Biochem 69: 889-896, 2013.
87. XIAO W, BIEBEI D, GUANGSI X, YU J, WEN Z, XI H, YOUJIA X: Iron overload increased osteoclastogenesis and aggravates the effects of ovariectomy on bone mass. J Endocrinol 226: 121-134, 2015.
88. YAMAGUCHI M, UCHIYAMA S, HASHIMOTO K: Oral administration in combination with zinc enhances β-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull 29: 371-374, 2006.
89. YOSHIZAWA S, BROWN A, BRCHOWSKY A, SFEIR C: Magnesium ion stimulation of bone marrow stromal cells enhances osteogenic activity, stimulating the effect of magnesium alloy degradation. Acta Biomater 10: 2834-2342, 2014.
90. YOUNESI S, PARSIAN H, HOSSEINI SR, NOREDDINI H, MOSAPOUR A, BIJANI A, HALALKHOR S: Dyshomeostasis of serum oxidant/antioxidant status and copper, zinc, and selenium levels in elderly physically disabled persons: an AHAP-based study. Biol Trace Elem Res 166: 136-141, 2015.
91. ZENG H, CAO JJ, COMBS GF JR: Selenium in bone health: roles in antioxidant protection and cell proliferation. Nutrients 5: 97-110, 2013.
92. ZIJLSTRA WP, BULSTRA SK, VAN RAAY JJ, VAN LEEUVEN BM, KUIJER R: Cobalt and chromium ions reduce human oseoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. J Orthop Res 30: 740-747, 2012.
93. ZOFKOVA I, NEMCIKOVA P, MATUCHA P: Trace elements and bone health. Clin Chem Lab Med 51: 1555-1561, 2013.